Compumedics Limited (ASX: CMP)

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. www.compumedics.com.au

Compumedics US FDA approval Orion LifeSpan MEG ASX CMP

US FDA approves Compumedics’ MEG neuroimaging technology enabling insurers to be billed

Compumedics (ASX: CMP) has collared US Food and Drug Administration approval for its neuroimaging technology, enabling insurers to be billed for...
Compumedics ASX CMP medical device profit Neuroscan DWL Elektronishe Germany US Australia brain monitor sleep blood flow

Compumedics boosts after tax profit by 133%

Compumedics (ASX: CMP) has delivered a net after tax profit of $2.8 million for the full year ending June 2018 – an increase of 133% on the prev...
Compumedics ASX CMP distribution agreement Japan Fukuda Denshi

Compumedics’ new distribution agreement strengthens ongoing growth in Asia’s neuro-diagnostic and monitoring marke...

Australia-based medical device company Compumedics (ASX: CMP) has continued its ongoing development and focus in Asia with a new three-year dist...
Compumedics Somfit Meinian Onehealth Healthcare Holdings joint venture sleep monitoring

Compumedics plans to ‘make history’ with Somfit health joint venture in China

Compumedics (ASX: CMP) has entered into an agreement with leading China-based health-check organisation Meinian Onehealth Healthcare Holdings (H...
Compumedics ASX CMP China distribution

Compumedics signs major distribution agreements in China worth at least A$15m

Compumedics (ASX: CMP) has negotiated a new distribution agreements with three of the company’s long-standing distributors in China, for its sle...
Compumedics ASX CMP eHeath neurology diagnostics

Compumedics confirms sustainable profitability with contract win and continued eHealth growth forecast

One of Australia’s leading medical device companies, Compumedics (ASX: CMP), announced this week, record sales orders of A$18.5 million for firs...
Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2020 Small Caps. All rights reserved.